Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
Clinical trial NCT05404945 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05404945
- Sponsor
- University of Virginia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-26
- Primary completion
- 2027-10-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.